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INTRODUCTION 
  The present report describes a female aged 25 years with 
postural orthostatic tachycardia syndrome (POTS). Her 
symptoms of weakness, palpitations, and tingling and cold-
ness in her feet were completely alleviated with Ivabradine. 
  A woman aged 25 years who is otherwise healthy pre-
sented to our emergency department (ED) with a 2-week 
history of fatigue, palpitations and severe weakness on 
standing, which began after a febrile viral illness. She   
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reported that after she stands she feels a racing of her heart 
followed by fatigue, numbness and tingling and coldness in 
her feet. On several occasions she fell to the floor without 
losing conciseness. Her physical examination was unreveal-
ing: her baseline heart rate (HR) was 80 bpm and supine 
blood pressure (BP) was 130/76mmHg. Baseline blood 
analysis, thyroid function test and electrocardiogram, and 
echocardiogram were normal. In the ED, the patient was 
asked to stand, and after 3 minutes she felt weak and tingling 
and a cold sensation in her feet. Her HR rose to 139 her BP 
was 125/70 mmHg (Fig. 1). The patient laid down prior to 
collapsing from lower limb weakness. Head up Tilt table test 
was performed: after 5 minutes her HR increased from 75 to 
140 without postural hypotension and recurrence of her 
symptoms was noted, the test was terminated. Her HR after 
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active stand confirmed the diagnosis of postural orthostatic 
tachycardia syndrome (POTS) (HR increase of >30 bpm 
from baseline or reaching >120 bpm within 10 minutes of 
standing in the absence of postural hypotension [1]. The pa-
tient was started on Ivabradine 5 mg bid, and after 2 days her 
symptoms improved markedly and she was able to stand 
without weakness or tachycardia. Her HR on active stand 
averaged 80bpm. Four months later the patient ran out of 
ivabradine her symptoms recurred. We reinstituted ivabrad-
ine at a dose of 5mg twice daily which led to remarkable 
improvement in her symptoms. 
DISCUSSION 
  POTS commonly occur between 15 and 50 years of age, 
and its prevalence is unknown [1]. However, in some reports 
it is suggested to be approximately 5 to 10 times as common 
as orthostatic hypotension [1]. In the past, multiple treatment 
modalities have been tried with limited success. The results 
with our case support 2 other case reports of the sinus   
node blocker ivabradine providing effective therapy for 
POTS [2, 3]. Randomized controlled trials are warranted to 
further evaluate its efficacy and safety. 
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Fig. (1). Patient HR at baseline and after active stand. 